跳至主要内容
临床试验/NCT06440278
NCT06440278已完成不适用

Multisite Feasibility of BA-HD: An Integrated Depression and Behavioral Risk Factor Reduction Coaching Program Following Acute Coronary Syndrome

The Miriam Hospital3 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2024年6月13日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
39
试验地点
3
主要终点
Study retention

研究概览

简要总结

Sixty adults who have experienced acute coronary syndrome within the past 2-12 months from three states (Rhode Island, North Carolina, Minnesota) will be randomized to either (1) a coaching program for depressed mood and health behavior change (Behavioral Activation for Health and Depression; BA-HD), or (2) Enhanced Usual Care. This study will evaluate the feasibility and acceptability of study procedures and BA-HD, and establish protocol and measurement harmonization across three sites in preparation for a future multi-site efficacy trial.

详细描述

Acute coronary syndrome (ACS) represents a significant public health burden, with the most recent estimates suggesting that over 1 million U.S. adults experience ACS per year. As individuals are acutely surviving ACS more often, the associated disease burden is increasing for both the healthcare system and the individual living post-ACS.

Poor engagement in health behaviors post-ACS contributes to risk for recurrent ACS and mortality. Modifiable behavioral contributors include smoking, medication non-adherence, physical inactivity, and poor diet. Approximately 20% of post-ACS adults experience depression and depression is associated with worse engagement in critical health behaviors, which in turn, increases subsequent progression of cardiovascular disease. Treatment of depression alone improves, but does not eliminate, behavioral nonadherence. Behavioral Activation is a robust counseling treatment for depression with evidence of improvements in depressive symptoms across varied populations (including those with medication conditions). BA seeks to improve mood by increasing environmental reinforcement through collaborative, values-guided setting of "activation goals." The goal setting focus and structure of BA allows for seamless integration of health behavior targets and thus offers a potential framework to integrate depression and health behavior treatment. BA-HD may be a useful strategy to depression and multiple health behavior improvement post-ACS. However, this possibility requires further testing.

The purpose of this study is to examine the feasibility and acceptability of a multisite pilot randomized controlled trial and test the initial potential effects of the intervention (BA-HD) on cardiovascular health and depressive symptoms relative to an Enhanced Usual Care control condition. Participants will be randomly assigned to either 12 weeks of tele-delivered BA-HD) or Enhanced Usual Care (i.e., one session of depression and heart disease education and provision of community mental health resources).

Primary endpoints are feasibility of multisite recruitment procedures (e.g., recruitment rates at each site), feasibility of intervention and control procedures (e.g., percent of enrolled participants who complete the study), study retention (e.g., percent of participants who complete 3 month follow-up), and acceptability of intervention content and intervention delivery and control procedures. The investigators hypothesize that the intervention content and delivery will be 1) feasible and 2) acceptable. The investigators will also examine changes in cardiovascular health, depressive symptoms, medication adherence, affect, and quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Medical chart-documented ACS (diagnosis of unstable angina, ST or non-ST elevation myocardial infarction) occurrence within the past 2-12 months.
  • Post-ACS depressed mood defined as a Patient Health Questionnaire(PHQ)--9 score ≥ 10 upon screening,
  • Non-adherence to and willingness to implement changes to ≥1 health behavior based on screening of:
  • Smoking/Tobacco exposure,
  • Physical Activity,
  • Sleep health,
  • Medication adherence
  • English-language fluency
  • Resides within 90 minutes (driving time) of each site with no plans to relocate beyond that range during study participation
  • Access to a telephone and/or videoconferencing capability
  • Has primary care provider
  • Address at which packages can be received

排除标准

  • Chart indication of significant cognitive impairment (e.g., chart-documented dementia), Current exacerbation of serious mental illness,
  • Suicidality,
  • Hearing impairment that prevents telephone/video communication for intervention and assessment purposes,
  • Current hospice care, and
  • Current engagement in cardiac rehabilitation or other regular counseling treatment targeting depression or health behavior change

研究组 & 干预措施

Behavioral Activation for Health and Depression

Experimental

干预措施: Behavioral Activation for Health and Depression (BA-HD) (Behavioral)

Enhanced Usual Care

Active Comparator

干预措施: Enhanced Usual Care (Other)

结局指标

主要结局

Study retention

时间窗: Week 26

Proportion of randomized participants who complete the 6 month assessment.

Treatment Acceptability

时间窗: Week 13

Client Satisfaction Questionnaire-8; Scores range from 8-32 with higher scores indicating greater treatment satisfaction.

Treatment engagement

时间窗: Week 13

Dose of treatment received (i.e., session attendance)

Recruitment feasibility

时间窗: Baseline

Number of participants randomized per month of recruitment

次要结局

  • 7-day point prevalence abstinence from smoking(Week 13, Week 26)
  • Depressive symptoms(Week 13, Week 26)
  • Non-HDL cholesterol(Week 13, Week 26)
  • Medication adherence (blood pressure regimen)(Week 13, Week 26)
  • Self-Reported Diet(Week 13, Week 26)
  • Cardiovascular Health(Week 13, Week 26)
  • 7 Day Moderate to Vigorous Physical Activity(Week 13, Week 26)
  • Sleep duration(Week 13, Week 26)
  • Body Mass Index(Week 13, Week 26)
  • Blood pressure(Week 13, Week 26)
  • Medication adherence (cholesterol regimen)(Week 13, Week 26)
  • Medication adherence (blood glucose regimen)(Week 13, Week 26)
  • All-cause mortality(Week 26)
  • Major Adverse Cardiac Events(Week 26)
  • Health Behavior Engagement Composite(Week 13, Week 26)
  • Self-Reported Moderate to Vigorous Physical Activity(Week 13, Week 26)
  • Self-reported sleep duration(Week 13, Week 26)
  • Hemoglobin A1C(Week 13, Week 26)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Emily C. Gathright, PhD

Research Scientist

The Miriam Hospital

研究点 (3)

Loading locations...

相似试验